Anti-COVID-19 human immunoglobulin (Lifefactors Zona Franca)

N/A

Report date: 2024/11/22 20:00:28

Base Information

Drug NameAnti-COVID-19 human immunoglobulin (Lifefactors Zona Franca)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryColombia
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLifefactors Zona Franca Sas
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLifefactors Zona Franca Sas
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A